Arrow International PICC Access Tray recalled for compromised sterility of injectable medications
Arrow International PICC Access Tray recalled for sterility risk
Arrow International included lidocaine, bupivacaine, and saline solution from a supplier with known quality issues in PICC Access Tray kits. The supplier's products have reported cases of drug ineffectiveness, and compromised sterility in injectable medications can cause serious injury. About 360 kits with specific lot numbers were distributed nationwide.
- If you have a PICC Access Tray with lot numbers 33F25C0224, 33F25D0647, 33F25G0390, or 33F25J0348, do not use it.
- Contact your healthcare provider or Arrow International for instructions on safe replacement or disposal.
- Report any adverse effects or product issues to the FDA MedWatch program.
Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if sterility of a water-based injectable product is compromised this could lead to serious or life-threatening injuries.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-2395-2026More Arrow recalls
- FDA-Device2026-06-24Arrow International hemodialysis kits recalled for contaminated anesthetic and saline solutions
- FDA-Device2026-06-24Arrow International PI CVC kits recalled for compromised sterility and drug ineffectiveness
- FDA-Device2026-06-24Arrow International PICC kits and stylets recalled for compromised sterility and drug ineffectiveness
- FDA-Device2026-06-24Arrow International PICC and JACC catheter kits recalled for contaminated anesthetic and saline components
- FDA-Device2026-06-24Arrow International Pacing PSI Kits recalled for potential drug ineffectiveness and sterility compromise
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief